Verapamil in atrial fibrillation in hyperthyroidism.
作者信息
Dahlstrøm C G, Ladefoged S D
出版信息
Br Med J (Clin Res Ed). 1987 May 30;294(6584):1384. doi: 10.1136/bmj.294.6584.1384.
Abstract
摘要
相似文献
1
Verapamil in atrial fibrillation in hyperthyroidism.维拉帕米治疗甲状腺功能亢进症伴心房颤动
Br Med J (Clin Res Ed). 1987 May 30;294(6584):1384. doi: 10.1136/bmj.294.6584.1384.
2
Immediate effects of intravenous verapamil on atrial fibrillation.静脉注射维拉帕米对心房颤动的即刻影响。
Cardiovasc Res. 1971 Oct;5(4):419-24. doi: 10.1093/cvr/5.4.419.
3
Hyperthyroid-induced atrial flutter-fibrillation with profound sinoatrial nodal pauses due to small doses of digoxin, verapamil, and propranolol.小剂量地高辛、维拉帕米和普萘洛尔导致甲状腺功能亢进诱发的心房扑动-颤动并伴有严重的窦房结停搏。
Clin Cardiol. 1989 Jan;12(1):45-7. doi: 10.1002/clc.4960120109.
4
[Verapamil in the treatment of atrial fibrillation in patients with thyrotoxicosis].[维拉帕米治疗甲状腺毒症患者的心房颤动]
Ugeskr Laeger. 1988 May 2;150(18):1114-6.
5
Hyperthyroidism and W P W syndrome.甲状腺功能亢进症与预激综合征。
Arch Inst Cardiol Mex. 1974 Jul-Aug;44(4):661-7.
6
Verapamil therapy of atrial fibrillation and atrial flutter following cardiac operation.心脏手术后房颤和房扑的维拉帕米治疗
J Thorac Cardiovasc Surg. 1982 Apr;83(4):590-6.
7
Atrial fibrillation and hyperthyroidism: a new look at their relationship and therapy with lidoflazine.心房颤动与甲状腺功能亢进：重新审视它们的关系以及利多氟嗪的治疗作用。
Postgrad Med J. 1975 Jan;51(591):4-9. doi: 10.1136/pgmj.51.591.4.
8
Atrial fibrillation with hyperthyroidism in a 14-year-old male.一名14岁男性患甲状腺功能亢进伴心房颤动。
Pediatr Cardiol. 2006 Nov-Dec;27(6):772-4. doi: 10.1007/s00246-006-1409-x. Epub 2006 Nov 7.
9
Thyrotoxic atrial fibrillation.甲状腺毒症性心房颤动
MedGenMed. 2005 Jan 4;7(1):74.
10
The beneficial effects of verapamil in chronic atrial fibrillation.维拉帕米在慢性心房颤动中的有益作用。
Arch Intern Med. 1979 Jul;139(7):747-9.
引用本文的文献
1
Thyroid storm with encephalopathy and cardiovascular symptoms refractory to medical management in an adolescent.一名青少年甲状腺危象伴脑病及心血管症状，药物治疗无效
Int J Crit Illn Inj Sci. 2020 Jan-Mar;10(1):38-41. doi: 10.4103/IJCIIS.IJCIIS_58_19. Epub 2020 Mar 6.
2
Clinical pharmacokinetics and endocrine disorders. Therapeutic implications.临床药代动力学与内分泌紊乱。治疗意义。
Clin Pharmacokinet. 1987 Dec;13(6):345-64. doi: 10.2165/00003088-198713060-00001.
本文引用的文献
1
New perspectives in the pharmacologic therapy of cardiac arrhythmias.心律失常药物治疗的新视角。
Prog Cardiovasc Dis. 1980 Jan-Feb;22(4):243-301. doi: 10.1016/0033-0620(80)90011-0.
2
Action of thyroid hormone on the transmembrane potentials from sinoatrial node cells and atrial muscle cells in isolated atria of rabbits.甲状腺激素对兔离体心房窦房结细胞和心房肌细胞跨膜电位的作用。
Cardiology. 1973;58(5):273-89. doi: 10.1159/000169643.
3
Cardiovascular response in hyperthyroidism. The influence of adrenergic-receptor blockade.甲状腺功能亢进症中的心血管反应。肾上腺素能受体阻滞剂的影响。
Arch Intern Med. 1972 Mar;129(3):426-9.
4
Haemodynamic effects of beta-adrenergic blockade in hyperthyroid patients with and without heart failure.β-肾上腺素能阻滞剂对伴有和不伴有心力衰竭的甲状腺功能亢进患者的血流动力学影响。
Br Med J. 1977 Jun 11;1(6075):1505-7. doi: 10.1136/bmj.1.6075.1505.
Zotero 插件